Eris acquires probiotics firm

NEW DELHI: Eris Lifesciences announced the acquisition of the prescription probiotics business of Velbiom Probiotics for Rs 50 crore. This strategic move strengthens Eris' franchises in metabolic wellness and women’s healthcare, says a company statement.Velbiom is a science-driven bio-therapeutics company committed to the advancement of India-specific microbiome based therapy and research. It is India’s exclusive probiotic company with a wide range of disease specific, strain specific and site-specific probiotic formulations, the statement adds.